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Flaviviruslation of the nonstructural protein 5 (NS5) is conserved feature of ﬂaviviruses,
but the kinase(s) responsible and function(s) remain unknown. Mass spectrometry was used to characterize
phosphorylated residues of yellow fever virus (YFV) NS5 expressed in mammalian cells. Multiple different
phosphopeptides were detected. Mutational and additional mass spectrometry data implicated serine 56
(S56), a conserved residue near the active site in the NS5 methyltransferase domain, as one of the
phosphorylation sites. Methyltransferase activity is required to form a methylated RNA cap structure and for
translation of the YFV polyprotein. We show the 2′-O methylation reaction requires the hydroxyl side chain
of S56, and replacement with a negative charge inhibits enzymatic activity. Furthermore mutational
alteration of S56, S56A or S56D, prevents ampliﬁcation in a viral replicon system. Collectively our data
suggest phosphorylation of NS5 S56 may act to shut down capping in the viral life cycle.
Published by Elsevier Inc.IntroductionPhosphorylation of amino acids is a commonmechanism to regulate
protein function in eukaryotes and is controlled by a wide variety of
tightly regulated cellular kinases and phosphatases. Viral protein
function and viral replication in several different viruses are dependent
upon conserved phosphorylation sites. For example, Vaccinia virus
virion assembly is dependent upon the phosphorylation state of the
protein A13 (Unger and Traktman, 2004). Phosphorylation of serine
clusters in the Ebola virus protein VP30 has been shown to directly affect
whether VP30 localizes to inclusion bodies within the cell or activates
transcription of viral RNA. This phosphorylation may serve as a switch
betweenpackagingand transcription in theEbola lifecycle (Modrof et al.,
2002). Despite theseexamples, relatively fewphosphorylation siteshave
been mapped on the amino acid level in viruses.
The family Flaviviridae includes many diverse medical pathogens
including hepatitis C virus (HCV) as well as arthropod-borne diseases
such as dengue virus (DV), yellow fever virus (YFV) andwest nile virus
(WNV). More than two billion people are at risk from dengue alone,
leading to an estimated 50 million cases annually, whichmay increase
further as the range of the mosquito vector increases due to climate
change (World Health Organization, 2002). Among Flaviviridae, the
most studied example is phosphorylation of NS5A of HCV,which existsiversit
^
y of Wisconsin-Madison,
nc.in both a basal (termed p56) and hyperphosphorylated (termed p58)
state. CK1αmediates some basal phosphorylation and the hyperpho-
sphorylation event. Silencing CK1α decreases HCV RNA replication,
but selective blockade of p58 formation actually increases HCV RNA
replication in the replicon model suggesting a complex interplay
between RNA replication and host kinases (Neddermann et al., 2004;
Quintavalle et al., 2007). Phosphorylation of NS5B, the RNA-dependent
RNA polymerase (RdRp) has also been shown to affect replicon activity
(Kim et al., 2004). Other Flaviviridae such as DV and YFV have
phosphorylated NS5 proteins (Kapoor et al., 1995; Morozova et al.,
1997; Reed et al., 1998). DV phosphorylation of NS5 affects NS5
interactions with the viral helicase NS3. A hyperphosphorylated form
of NS5 was found to localize to the nucleus away from the cytoplasmic
sites of viral replication (Forwood et al., 1999; Kapoor et al., 1995). A
nuclear localization sequence is present in DV NS5 and is phosphory-
lated in vitro by host CKII but the relationship between phosphoryla-
tion and nuclear localization has yet to be fully elucidated (Pryor et al.,
2007).
NS5 has two separate activities encoded in distinct domains. The C-
terminal 600 amino acids of NS5 contain RdRp activity and the N-
terminal 300 amino acids represent the methyltransferase domain,
which methylates the cap structure found on the 5′ end of viral RNA.
Both RNA polymerase and methyltransferase activity are essential for
the viral lifecycle (Khromykh et al., 1998; Khromykh et al., 1999, Ray
et al., 2006). Viruses requirehost translationalmachinery to synthesize
viral proteins and a methylated cap structure greatly increases
translation of RNA (Furuichi and Shatkin, 2000). The ﬂavivirus NS5
activity includes both 2′-O methylation and N7 methylation, which is
Fig. 1. Expression of wild-type (WT) YFV NS5, empty vector control (EV) and their mass spectrometric (MS) analysis. (A) HEK293T cells were transfected with WT YFV NS5 and EV
separately. After 48 h of transfection the proteins were pull down by 6X His and identiﬁed in 10% SDS-PAGE gel with colloidal staining method. 100 kD band is correspond toWT YFV
NS5 which is absent EV control lane. (B) MALDI-TOF full scan spectra correspond to 100 kD size band of WT YFV NS5 (⁎) and EV control lane (⁎⁎). The EV MS data was used as a
background control in each peptide analysis.
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methylation reaction (Ray et al., 2006; Schubert et al., 2003).
This study reports the ﬁrst mapping of YFV NS5 phosphorylation
sites on an amino acid level. Both mass spectrometry and site-directed
mutagenesis were used to identify S56 of YFV NS5 as a phosphorylated
amino acid. Our data show that not only that S56 is phosphorylated,
but also that the hydroxyl group is required for 2′-O methylation in
vitro, yet is not essential for SAH binding. Finally, S56 is required for
replication of viral RNA, but not for translation of exogenously capped
viral RNA. While it is unclear the extent to which S56 phosphorylation
occurs in during cellular infection, our results suggest phosphoryla-
tion of S56 could alter the methyltransferase activity and shut down
viral translation.
Results
Multiple phosphorylation sites occur in YFV NS5, including serine 56
Phosphorylation is an important way to regulate signaling
cascades and protein activity, and has been shown to play a role in
several viral processes (Jakubiec and Jupin, 2007; Mohr, 2006). To
determine phosphorylation sites in YFV NS5, the protein was
expressed in a form amenable to puriﬁcation from mammalian cells,
and then characterized by mass spectrometry (MS). Amino acids 1–
900 of YFV NS5 were ampliﬁed from YF-R.luc2A-RP and cloned into a
pIRES eukaryotic expression vector in frame with a 6X His nickel
afﬁnity tag. DNA was transfected into HEK293T cells, which supportFig. 2.Map of identiﬁed phosphorylation sites. A schematic diagram of the YFV Nonstructural
phosphopeptides by mass spectrometry. The peptide 49–61 was further characterized becau
Potential phosphorylated residues are shown in bold italics.viral replication (data not shown). YFV NS5 was puriﬁed from cell
lysates by metal afﬁnity chromatography, excised from SDS-PAGE, and
after tryptic digest, was analyzed by MS. For background corrections,
an empty vector control was transfected and prepared in parallel for
MALDI-TOF analysis even though the ∼100 kD YFV NS5 was absent
from this preparation (Fig. 1). The MS peaks obtained from this
negative control spectra did not correspond to any peaks in the MS
identiﬁed as potential phosphopeptides. Fig. 2 shows six peptides that
were identiﬁed as 80 Da larger than the predicted mass. Each contains
at least one serine/threonine phosphoacceptor. Only masses from
approximately 50% of the YFV NS5 protein were identiﬁed (with or
without an extra phosphate) so some phosphorylation sites may not
have been identiﬁed. The masses for each of these peptides were no
longer detected upon treatment of the puriﬁed NS5 with Calf
Intestinal Phosphotase consistent with them being phosphorylated
peptides.
Further analysis was performed on peptide 49–61 because it had
both structural data (Assenberg et al., 2007; Egloff et al., 2002;
Mastrangelo et al., 2007; Zhou et al., 2007) and it contained a serine
that was completely conserved for all viruses in the ﬂavivirus genus. Fig.
3A is a MALDI-TOF plot showing the peptide (49–61, VDTGVAVSRGTAK)
with amass of 1341.7876,which is an increase of 80Daover theexpected
massof this peptide, suggestingaphosphorylatedamino acid. In order to
conﬁrm that Fig. 3A corresponds to a phosphopeptide, half of tryptic
digested NS5 peptides was treated with calf intestinal alkaline
phosphatase (CIAP). Fig. 3B shows the peptide present at 1341.7876
was lost after CIAP treatment suggesting the presence of a phosphate onProtein5 (NS5) showing the location and coordinate number of amino acids of identiﬁed
se it contained a completely conserved serine and crystallographic data was available.
Fig. 3.Mass spectrometric analysis of tryptic digested peptides of wild-type YFV NS5 expressed in HEK293T cells by MALDI-TOF. (A) Spectra of singly charged monoisotopic peak of
single phosphorylated peptide corresponding amino acid 49–61 with a mass of 1341.7876. The mass was calculated with an addition of 79.9 for posttranslational modiﬁcation of one
phosphorylated site. (B) YFV NS5 phosphopeptides treated with 20 U of CIAP to remove phosphate showing the loss of 1341.7876 peak as present in A. (C) Recovery of the spectra of
singly charged monoisotopic peak of YFV NS5 corresponding amino acid 49–61 with a mass of 1262.5821 indicated the loss of phosphate following CIAP treatment.
278 D. Bhattacharya et al. / Virology 380 (2008) 276–284one of three acceptors, T51, S56, or T59. Identiﬁcation of the resultant
dephosphosphorylated peptide is shown in Fig. 3C with a mass of
1262.5821 correspond the same peptide as Fig. 3A (49–61).Fig. 4.Mass spectrometric analysis of tryptic digested peptides of mutated YFV NS5 expresse
the mass of 1522.7387 corresponding to amino acid 43–57 showing YFV NS5 T51 was not pho
mutated peptide with a mass of 1309.6541 corresponding amino acid 49–61 showing S56 cBoth S56 and T59 were mutated to alanine in the NS5 expression
vector and then analyzed for shifts in mass corresponding to a loss of
phosphorylation (Figs. 4A, B). Fig. 4A shows the mass of 1522.7387d in HEK293T cells by MALDI-TOF. (A) Spectra of singly charged S56A mutated peptide at
sphorylated. (D) Recovery of single chargedmonoisotopic peak of phosphorylated T59A
ould be the only phosphosite.
Fig. 5. LC–MS/MS ionizations of the singly phosphorylated peptide corresponding to amino acid 49–57 after in gel tryptic digest of YFV NS5 protein. The peptidewas passed through a
C-18 HPLC column before fragmentations. Major fragment ions are labeled with their corresponding b (C-terminal) and y (N-terminal) ion and their charge state. The peak at m/z
809.00 represents the singly charged phosphorylated Serine (Sp) at the position of 56 in YFV NS5.
279D. Bhattacharya et al. / Virology 380 (2008) 276–284was detected for the S56A mutant, which is the expected mass for
the alanine containing peptide in an unphosphorylated state. As T51
is also present in fragment 43–57, the lack of an increase in mass
suggests that T51 is not phosphorylated, or that S56 is required for
T51 phosphorylation. To determine whether T59 is phosphorylated
the T59A mutant was analyzed by mass spectrometry in a similar
fashion. We observed a peptide with a mass of 1309.6541, which is
the predicted size for a VDTGVAVSRGAAK peptide with a single
phosphorylation, suggesting that S56 (or possibly T51) is the most
likely phosphorylated amino acid in the fragment originally observed
in Fig. 3A. To identify the phosphorylated amino acid deﬁnitively, the
wild-type expressed YFV NS5 was analyzed by ESI LC–MS/MS (Fig.
5). The peptide 49–57 (VDTGVAVSR) was found to have a single
phosphorylation site and by measuring the masses of individual
amino acids, S56 was determined to be phosphorylated.Fig. 6. Crystallographic and bioinformatics analysis of the ﬂavivirus methyltransferase active
in blue. Hydrogen bonds between SAH and S56 are shown by yellow dotted lines (B) Dir
methyltransferase. The atoms shown in green are the canonical KDKE active site of all methy
around S56 from 715 distinct ﬂaviviral genomes. The phosphorylated serine (S56) is starred.
weblogo.berkeley.edu/).S56 may interact with S-adenosyl homocysteine in the YFV NS5
methyltransferase
Themethyltransferase domains ofWNV and DV have recently been
crystallized (Egloff et al., 2002; Zhou et al., 2007). Using biochemical
and crystallographic analysis, several amino acids required for the
methyltransferase reactionwere identiﬁed as well as the binding sites
for the 5′ cap or GTP and SAM, which are all highly conserved among
ﬂaviviruses (Dong et al., 2008). As shown in Fig. 6A, S56 lies very near
the KDKE active site tetrad that catalyzes the transfer of a methyl
group from SAM to the viral RNA. The hydroxyl of S56 directly
interacts with S-adenosyl homocysteine, a product of SAM-dependent
methylation (Egloff et al., 2002; Zhou et al., 2007). The addition of a
phosphate to S56 would most likely alter the interaction between S56
and SAM, changing the orientation of the methyl donor of SAMsite. (A) Pocket of Dengue Virus methyltransferase, with SAH in atomic coloring and S56
ect interactions between S56 (dark blue) and SAH in the active site of Dengue Virus
ltransferases. The orientation of (A) and (B) are the same. (C) Logo analysis of the region
(alignment: http://athena.bioc.uvic.ca/workbench.php?tool=vocs&db=, for Logo: http://
Fig. 8. SAH binding of YFV methyltransferases. SAH was covalently bound via the free
amino group of the homocysteine moiety to Sepharose using an N-hydroxysuccinimidyl
linkage. Puriﬁed 6X His tagged methyltransferases (amino acid number G1 to D296) of
YFV wild-type (WT), S56A, S56D and CFP were incubated overnight with SAH bound to
Sepharose and after being washed with 50 column volumes of PBS+0.5% NP40, bound
protein was eluted, spotted on a PVDF membrane via a dot blot apparatus and the
amount of bound protein was measured by western blot with anti-His antibody.
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SAM (Fig. 6B). A sequence alignment and WebLogo analysis of more
than 700 ﬂavivirus NS5s shows a high level of conservation of not only
S56, but also surrounding residues that typically constitute a kinase
recognition sequence (Fig. 6C) suggesting this region or at least S56
has evolutionary constraints on it.
S56 is required for in vitro 2′-O methylation of viral RNA
S56 may serve a critical function in methyltransferase activity. In
vitro methylation studies were performed to measure the effects of
mutations on YFV NS5 methyltransferase activity. Wild-type YFV NS5
methyltransferase, as well as two mutants, S56A and S56D, were
cloned into an E. coli expression vector. After puriﬁcation the 2′-O
methyltransferase activity of each mutant was compared to both
vaccinia 2′-O methyltransferase and wild-type YFV 2′-O methyltrans-
ferase activity and the products analyzed by thin layer chromato-
graphy (Dong et al., 2007). As shown in Fig. 7, WT NS5 MT was able to
2′-O methylate the N-7 methylated 5′ 250 bp fragment of the YFV 5′
RNA. S56A mutant NS5 was unable to carry out 2′-O methylation,
indicating that this residue is essential for methyltransferase activity.
Similarly, the S56D mutant, that mimics a phosphorylated serine,
lacked 2′-Omethyltransferase activity as well. These data suggest that
phosphorylation of S56 may inhibit the methyltransferase activity of
YFV NS5.When the same experimentwas carried out with puriﬁed DV
NS5 methyltransferase, similar results were observed (data not
shown).
S56 hydroxyl is not required for SAH binding in the active site of YFV
methyltransferase
Since structural studies have shown that S56 interacts with SAH, it
is possible that S56 is involved in the binding of SAH/SAM to the active
site of the YFV methyltransferase (Zhou et al., 2007). In order to
measure the effects of mutations of S56 on SAH binding, SAH was
anchored to Sepharose 4B beads via an N-hydroxysuccinimidyl
linkage. Puriﬁed protein was incubated with the SAH-Sepharose
beads overnight and after being washed with 25 column volumes of
wash buffer, bound protein was eluted and spotted on a dot blotter.
The amount of protein was measured via western blot and there was
no difference detected between the ability of the wild-type YFV
methyltransferase and the S56A mutant to bind to SAH (Fig. 8). While
some S56D binding to SAH-Sepharose beads could be detected above
the level of a nonSAH binding control protein (CFP) it was clearly
impaired relative to either S56A or wild-type.Fig. 7. In vitromethylating activity of YFV NS5s. Authentic YFV RNA corresponding to the
ﬁrst 250 bp that had been capped by VP39 of Vaccinia virus as well as S-adenosyl
methionine were incubated with either a mock (1), vaccinia 2-O methyltransferase (2),
the wild-type YFV methyl transferase (3), and mutant YFV NS5s S56D (4) and S56A (5).
This reaction was then run out by TLC and the ability to perform 2′-O methylation was
compared (middle spot, m7GpppA).S56 mutant YFV replicons are unable to replicate in HEK293T cells
Individual YFV replicons were constructed containing the S56A or
the S56D mutant (Fig. 9A). In vitro synthesized capped replicon RNA
was transfected into HEK293T cells to measure the ability of various
replicons to replicate over 24 h. Methylation is essential for ﬂavivirus
replicons to replicate (Dong et al., 2008; Khromykh et al., 1999). Using
a luciferase-reporter replication assay wemonitored the production of
protein from the input RNA, and the later replication of the RNA by
viral proteins via luciferase that correlates with RNA levels (Jones
et al., 2005). At 6 h post-transfection, both wild-type and mutant
replicons showed increased luciferase readings compared to the initial
2-hour time point (Fig. 9B). The initial increase represents translation
of transfected RNA prior to RNA replication, similar to the GAAmutant
replicon, which is unable to copy RNA due to mutations in the active
site of the polymerase. There was a decrease in signal at 14 h for all
replicons. The wild-type replicon, however, was able to replicate the
input RNA replicate and had the highest luciferase readings 24 h post-
transfection. S56A and S56D both showed little translation after initialFig. 9. YFV replicon constructs and comparison of the effects of S56 mutations of YFV
replicon growth. (A) Schematic representation of YFV replicon construct (Jones et al.,
2005) where the NS5 S56A and S56D mutations were done and used to measured the
luciferase activity. ⁎ Indicates ﬁrst 22 amino acids of capsid protein for RNA cyclization
sequences; R. Luc, Renilla luciferase; 2a, 17 amino acid residue auto proteolytic peptide
from foot and mouth disease virus; black box, NS1 signal sequence; gray box,
nonstructural protein sequences; arrow indicates in NS5 where S56A and S56D
mutations were done. (B) YFV replicon RNA was transfected into HEK293T cells and
incubated over 24 h. At various time points, cells were lysed and luciferase activity
corresponding to translation of viral RNA was measured. Wild-type virus (ﬁlled
diamonds), a GAA polymerase-dead mutant (circles) were used as controls for S56A
(triangles) and S56D (squares). Values were normalized to readings obtained at 2 h
post-transfection to control for transfection efﬁciency.
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shown). Wild-type replicon showed maximum growth after 24 h, in
accordance with the length of YFV replication cycle and the wild-type
growth curves looked similar to those seen for other ﬂavivirus
replicons (Holden et al., 2006). These data indicate S56 is required
for replication of viral RNA and that methylation is an important part
of this process.
Discussion
In this work we performed the most detailed analysis of ﬂaviviral
phosphorylation to date and identify six phosphorylated peptides
from YFV NS5 all containing at least one serine or threonine. The
putative serine/threonine phosphoacceptor sites were largely con-
served between different YFV genomes, but the conservation
weakened when comparisons were made with more distant
relatives including Tick borne ﬂaviviruses. At least one peptide
(peptide 839 see logos in supplemental data) contained a tyrosine
highly conserved throughout the genus, while the threonine
(position 844) was speciﬁc to YFV genomes. Previous studies
detected only phosphothreonine/serines in ﬂavivirus (Kapoor et al.,
1995; Morozova et al., 1997; Reed et al., 1998). Additional
experiments will be required distinguish between a YFV speciﬁc
phosphothreonine, and a phosphotyrosine that is now detectable
due to advances in methodology. One peptide corresponding to a
portion of the active site the methyltransferase portion of NS5 with
three potential phosphoacceptor sites was examined in greater
detail. Both mutational and additional mass spectrometry data
identiﬁed the phosphoacceptor site as serine 56, which is
completely conserved in the genus ﬂavivirus. Mutational and
biochemical analyses indicated this residue is essential for YFV
RNA 2′-O methylation and replication.
RNA capping and methylation are essential processes for viruses
that depend upon the full host translational apparatus for transla-
tion of viral proteins. RNA capping methyltransferases are hypothe-
sized to function by aligning the methyl donor group of SAM with
the RNA such that methyl transfer may occur via an SN2 reaction
(Fabrega et al., 2004). S56 interacts with the carbonyl group of SAM
in order to position the donor methyl group and the addition of a
phosphate at S56, from both a charge and steric standpoint, would
almost certainly reposition the methyl donor group of SAM. In the
crystal structure of Ecm1, a eukaryotic 2′-O RNA methyltransferase,
Lysine 54 showed similar bonding geometry as S56 in relation to the
carbonyl group of SAM. K54 mutants were found to be catalytically
inactive (Fabrega et al., 2004). Recently, a serine to alanine mutant
at S56 in WNV was also shown to be defective for methylation and
viral replication (Dong et al., 2008). Dong et al also found that R57
may play a role in RNA binding and is required for methyltransfer-
ase activity in WNV. The addition of a phosphate at S56 may inhibit
methyltransferase activity in two ways. First, the phosphate blocks
direct access to S56 and secondly may reposition another essential
amino acid, R57. Both S56 and R57 are conserved among all 715
ﬂavivirus examined (Fig. 6C). While both S56A and S56D defective
in 2′-O methylation the hydroxyl group of S56 does not appear to be
essential for SAM binding as long as it is not replaced with a
negative charge (Fig. 8).
Our work is consistent with and extends prior work that
multiple viral serines and threonines in NS5 can be phosphorylated
(Kapoor et al., 1995; Reed et al., 1998) and these modiﬁcations may
be reversible. Neither the phosphomimetic D, nor the unpho-
sphorylatable A at position 56 were functional in a replicon (Fig. 9).
This may imply a transient phosphorylation at this site. At least in
the case of dengue virus, one event occurs late in the lifecycle and
coincides with a “hyperphosphorylated” form of NS5 (Kapoor et al.,
1995). Molecular mapping of phosphorylation sites gives clues
toward the identities of kinases involved. For example the S56 siteis predicted by neural net bioinformatic program (NetPhosK (Blom
et al., 2004)) to be a CK1 recognition site, the same kinase
responsible for hyperphosphorylation in HCV (Quintavalle et al.,
2007). Our data do not directly show that S56 is phosphorylated in
the course of a normal infection. Our data does suggest that the
hydroxyl sidechain of S56 is required for methylation to occur. We
do not predict that S56 would be phosphorylated early in the
course of infection if at all. One attractive possibility though, is that
at least some NS5 molecules are phosphorylated at S56 late in
infection. Phosphorylation at S56 of even a portion of NS5
molecules would serve to decrease capping and protein synthesis
viral protein and allow more viral RNA to be used for replication.
At present we have no data that argues phosphorylation regulates
the conversion from translation to replication, but the shunting of
some RNA molecules for replication is an essential step for the
virus. Further investigation is required to determine the role of
phosphorylation in this step. The identiﬁcation of these phospho-




The YF-R.luc2A-RP, as well as YF-R.luc2A-RP GAA, replicons were
provided by Dr. Richard Kuhn, Purdue University, West Lafayette, IN
(Jones et al., 2005). YF-R.luc2A-RP contains an additional G to facilitate
T7 transcription yet is competent for both replication and expresses
Renilla luciferase as a reporter. The YF-R.luc2A-RP GAA replicon is
deﬁcient in RNA replication due to mutations in the active site of the
polymerase.
YFV NS5/IRES/GFP constructs
Full-length YFV NS5 (PFLYF17D, GenBank Accession No. X03700)
was ampliﬁed from a DNA template by PCR with primers that
introduce a XhoI site, Kozak sequences and an in frame start codon
ATG 5′ to the NS5 sequence and a PacI site, 6X His in frame and a stop
codon at 3′ end. ∼2.8 kb PCR product was digested and cloned to
pIRES/GFP bicistronic mammalian expression vector (provided by Dr.
Kouacou V. Konan, Penn State University, University Park, PA) in XhoI–
PacI sites and sequenced.
YFV NS5 mutant/IRES/GFP constructs
YFV NS5 S56A and YFV NS5 T59A were generated by an overlap
PCR strategy (Ho et al., 1989) with introduction of individual
mutations in overlapping primer pairs. Second step PCR products
were directly cloned into WT pYFV NS5 6X His IRES/GFP construct by
replacing XhoI–SacII fragment and sequenced.
YFV NS5 methyltransferase constructs
888 nt long (YFV NS5 amino acid coordinate number G1 to
D296) fragment was ampliﬁed from YFV NS5/IRES/GFP construct by
PCR with introduction of BamHI site at the 5′ and HindIII site at 3′
ends. The PCR products were then cloned directly to pQE-30 N-
terminus 6X His prokaryotic expression vector (Qiagen, Valencia,
CA) in frame at BamHI–HindIII sites and sequenced. YFV NS5 S56A
and YFV NS5 S56D were generated by overlap PCR strategy (Ho
et al., 1989) with introduction of individual mutation in overlap
primer pairs. Second step PCR products were directly cloned to
pQE-30 N-terminus 6X His WT YFV NS5 MTase construct by
replacing XhoI–SacII fragment and sequenced. For negative control
construct full length (717 nt long) of enhanced cyan ﬂuorescent
protein (CFP) was cloned in same pQE-30 N-term 6X His vector and
sequenced.
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Quick-change method was performed to generate YF-R.luc2A-RP
NS5 S56A and YF-R.luc2A-RP NS5 S56D replicons. The PCR reactions
consisted of 200 ng YF-R.luc2A-RP replicon template DNA, 40 pmol of
each mutated primer, 25 mM dNTPs and 2.5 U Pfu Ultra II Fusion HS
DNA polymerase (Stratagene, La Jolla, CA). Ampliﬁcations were carried
out for 30 cycles at 92 °C for 10 s followed by both annealing and
extension at 68 °C for 30 s/kb of plasmid. 40 μl of the PCR reactions
were directly treated with 20 U of DpnI (New England Biolabs,
Ipswitch, MA) at 37 °C for 2 h and inactivated DpnI enzyme at 80 °C
for 20 min. 2 μl of these DpnI treated linear PCR products were
electroporated in to E. coli Top10 electrocompetent cells. Desalted
primers were synthesized (IDT, Coralville, IA) and were as follows:
for NS5 S56A the forward primer was 5′-GGGGTGGCGGTCGCC-
AGGGGGACCGCAAAGTTAAGG-3′ and for NS5 S56D the forward
primer was 5′-GGGGTGGCGGTCGACAGGGGGACCGCAAAGTTAAGG-3′
(bold letters are where the mutation introduced). The reverse
primers were exactly the complementary sequences of the respective
forward primers.
Expression and puriﬁcation of YFV NS5 proteins in HEK293T cells
GFP in the IRES vector was used as transfection/expression
marker. Transfection of the empty vector was performed in parallel
in each case as a negative control. 15 μg of either YFV NS5 DNA or
empty vector DNA were transfected in 70–80% conﬂuent HEK293T
cells in a T75 ﬂask. HEK 293T cells were maintained at 37 °C in 5%
CO2 incubator in DMEM (Invitrogen, La Jolla, CA) supplemented with
10% FBS and 1X Penicillin–Streptomycin solution. TransIT-LT1
(MirusBio, Madison, WI) was used as a transient transfection
reagent and the transfection was carried out in presence of Opti-
MEM1 (Invitrogen, CA). After 48 h of transfection the cells were
collected, washed several times in 10 mM phosphate buffer and
homogenized in ice cold lysis buffer (50 mM NaH2PO4, 2H2O;
300 mM NaCl; 10 mM Imidazole; 0.05% Tween-20; 1% NP-40, pH
8.0) in presence of EDTA-free 1X halt protease inhibitor cocktail and
1X halt phosphatase inhibitor cocktail (Thermo Fisher Scientiﬁc,
Waltham, MA). After collecting the lysate by centrifugation, the 6×
His recombinant proteins were bound with lysis buffer equilibrated
Ni-NTA magnetic agarose beads (Qiagen, CA) at 4 °C for 2 h 30 min.
The beads were washed thoroughly in wash buffer (50 mM
NaH2PO4, 2H2O; 300 mM NaCl; 10 mM Imidazole; 0.05% Tween-
20; pH 8.0) and the 6X His proteins were eluted from magnetic
beads in elution buffer (50 mM NaH2PO4, 2H2O; 300 mM NaCl;
250 mM Imidazole; 0.05% Tween-20; pH 8.0).
Sample preparations for MS
6X His puriﬁed proteins (both experimental and empty vector
control) from HEK293T cells were run in 10% SDS-PAGE gels. The
gels were stained in GelCode Blue stain (Thermo Fisher Scientiﬁc,
MA). An ∼100 kD band was excised from the gel. Gel pieces
containing protein were destained in 25 mM NH4HCO3 in 50% ACN
at 37 °C, reduced in 50 mM TCEP in 25 mM NH4HCO3 at 60 °C,
alkylated in 100 mM IAA in 25 mM NH4HCO3 in the dark at room
temperature, dehydrated in 100% ACN at room temperature and
digested with trypsin (Trypsin Gold, Mass Spectrometry Grade —
Promega, Madison, WI) at 30 °C overnight. Peptides were collected
and divided in two. Half of these peptides were enzymatically
dephosphorylated with 20 U of CIAP (New England Biolabs, Beverly,
MA) at 37 °C for 2 h and the reaction was stopped by adding 50 mM
EDTA. Both phosphorylated and dephosphorylated peptides were
cleaned up with OMIX C18 Zip-Tip (Varian, Harbor City, CA) and
eluted either in 0.1% TFA in 75% ACN for MALDI-TOF or in 0.1%
formic acid in 50% ACN for ESI analysis.Sample loading and analysis
Both Matrix-Assisted Laser Desorption/Ionization-Time of Flight
(MALDI-TOF) and Electrospray Ionzation (ESI) were done at the
University of Wisconsin mass spectrometry facilities. 10 mg/ml α-
cyano-4-hydroxycinnamic acid (Sigma-Aldrich, St. Louis, MO) was
used as matrix and added in the samples in a ratio of 1:1. Samples
were spotted in a MALDI plate and dried at room temperature. MALDI
datawere obtained using a MDS SCIEX 4800MALDI-TOF/TOF (Applied
Biosystem, Foster City, CA) instrument. The mass spectra were
collected from m/z 700 to 4000 and preliminary analysis was
performed in GPS Explorer software (Applied Biosystem, Foster City,
CA). After Mascot database (Matrix Science, London, UK) search and
the data comparison before and after CIAP treatment (wild-type only),
detailed matching of mass with peptide identiﬁcation was performed
in MS-Digest tools (a web based software in ProteinProspector, v
4.27.1). ESI mass spectrometry was performed for LC–MS/MS analysis.
ESI precursor ion scan mass spectra were obtained using Finnigan LTQ
Linear Ion Trap mass spectrometer (Thermo Fisher Scientiﬁc)
equipped with a nanoelectrospray ion source. Zorbax 300SB-C18
nanoﬂow HPLC column (150 mmX75 μm, Agilent Technologies, Santa
Clara, CA) was eluted with a linear gradient of water–acetonitrile in
the presence of 0.1% formic acid at a ﬂow rate of 0.2 μl/min. Rest of the
protocol was followed as described elsewhere (Black et al., 2007) and
full scan spectra were recorded from m/z 200–2000 followed by MS/
MS spectra in Xcalibur software (Thermo Fisher Scientiﬁc). MS/MS
spectra of detected phosphopeptide were searched against the FASTA
database using Sequest search program within BioWorks Rev3.3
software (Thermo Fisher Scientiﬁc).
Expression and puriﬁcation of YF methyltransferase domain and CFP in
bacterial cells
The pQE-30 6X His tag methyltransferase constructs and pQE-30
6X His tag CFP construct were transformed in M15[pREP4] E.coli
(Qiagen, CA). The cells were grown at 37 °C until an OD600 of 0.7 and
expression was induced by adding 1 mM isopropylthio-β-D-galacto-
side (IPTG) at 28 °C for 5 h. The recombinant proteins were then bound
to Ni-NTA agarose (Qiagen) and puriﬁed according to manufacturer
protocol.
SAH afﬁnity chromatography
Five ml of SAH-labeled Sepharose was made as follows: NHS-
Sepharose (Sigma, St. Louis, MO) was spun at 1000 g for 1 min and
the supernatant was removed. 40 ml of 1 mM HCl was added to the
Sepharose and then removed by centrifugation. 75 mmol of SAH
was dissolved in coupling buffer (0.2 M NaHCO3, 0.5 M NaCl, pH 8.3)
and incubated with the activated NHS-Sepharose overnight in a
rotary shaker at 4 °C. Supernatant was removed by centrifugation
and the beads were blocked for 2 h in 10 ml of 0.1 M Tris HCl, pH
8.5. After blocking, beads were washed with ﬁve cycles of
alternating low pH (0.1 M Acetate buffer, 0.5 M NaCl, pH 4.5) and
high pH (0.1 M Tris HCL pH 8.5) and stored in 20% ethanol at 4 °C.
To measure the ability of each YFV methyltransferase to bind SAH,
100 μl of beads were sedimented by centrifugation to remove
ethanol and washed twice with 500 μl of binding buffer (0.2 M KCl,
50 mM Tris HCl pH 7.0, 1 mM β-mercaptoethanol, 1 mM dithio-
threitol). Beads were then incubated with 100 ng of puriﬁed
recombinant 6X His-NS5 in 500 μl of binding buffer overnight at
4 °C. Unbound protein was collected by centrifugation at 1000 g for
1 min and beads were washed with 50 column volumes of PBS+
0.5% NP40 and collected. Bound protein was eluted in 4 M guanidium
HCl and spotted via a Minifold I microsample ﬁltration manifold dot
blotter (Schleicher & Schuell, Keene, NH) onto Immobilon-P PVDF
membrane (Millipore, Billerica, MA). After drying, protein was
283D. Bhattacharya et al. / Virology 380 (2008) 276–284visualized via Western blot using a 6X His antibody (Qiagen) and
developed via ECL.
RNA substrates
RNA substrates for methyltransferase assays were generated as
described elsewhere (Dong et al., 2007). YFV RNA representing the
ﬁrst 250 bp of the genome was in vitro transcribed from PCR products
generated with primers 1 (TAA TAC GAC TCA CTA TTAGTA AAT CCT GTG
TGC TAA TTG AG) and 2 (AAC ACC TCT TGA AGG TCC AG). Primer 1
contains a bacteriophage T7 class II Φ2.5 promoter (italicized) that
allows for ATP-initiated transcript using T7 RNA polymerase (Coleman
et al., 2004). In vitro YFV transcripts were capped with (α-32P) G⁎TP
and Vaccinia virus guanylyltansferase (Applied Biosystems) in the
presence of SAM to generate m7-G⁎pppA-RNA. The resulting capped
transcripts were puriﬁed through a G-50 column (Amersham, Piscat-
away, NJ) and used for 2′-O methylations.
Cap methylation assays
The 2′-Omethylation reactionwas performed at 22 °C for 2 h in 2′-
O buffer (50 mM glycine, pH 10, 2 mM DTT, 1 mM MgCl2, and 6 mM
KCl) containing 5000 CPM m7G⁎pppA-YFV RNA, 1 µg puriﬁed
Methyltransferase and 100 µM SAM. Control m7GpppAm-RNA was
prepared using Vaccinia virus Cap 1 methyltransferase (Epicentre,
Madison, WI) following the manufacturers protocol. Methylation
reactions were digested for 1 h at 68 °C with Nuclease P1 (US
Biological, Swampscott, MA) and analyzed by polyethyleneimine
cellulose thin layer chromatography in 0.2 M ammonium sulfate.
Analysis of the effects of mutations on replicon growth
YFV replicon DNAwas linearized by treating with XhoI for 4 h and
ethanol precipitated. Linearized DNA was then used to generate full-
length replicon RNA using the mMessage mMachine in vitro RNA
transcription kit (Ambion, Austin, TX), and cleaned up via LiCl
precipitation. HEK293T cells were transfected with puriﬁed RNA by
plating 50,000 cells per well of a 48-well plate and incubating
overnight. Mediawas removed and replaced with 250 μl of newmedia
before transfection. Transfectionmixture contained 0.25 μg of RNA per
well in 25 μl of OptiMEM-1 growthmedia, along with 0.25 μl of mRNA
Boost and 0.5 μl of Trans-IT mRNA transfection mixture (MirusBio,
Madison, WI). Transfection mixture was incubated for 3 min before
being added to eachwell. Cells were then incubated for 2, 6,12, or 24 h
at which time media was removed and cells were lysed with 50 μl of
Renilla Lysis buffer from the Renilla Luciferase Assay system (Promega,
Madison, WI). 10 μl of cell lysate was added to 50 μl of Renilla
Luciferase Assay buffer and read in triplicate on a Turner Designs
TD20/20 Luminometer.
Crystallographic and bioinformatics analysis
All crystallographic analysis was performed on a crystal structure
of the dengue methyltransferase including 7MeGpppA and SAH (pdb
id 2P3O, (Egloff et al., 2007)) using MacPyMol (DeLano, www.pymol.
org). Logo analysis was performed withWebLogo after aligning all 715
ﬂaviviral methyltransferases available in the Viral Bioinformatics
Resource Center using the Viral Orthologous Cluster program (Crooks
et al., 2004; Hiscock and Upton, 2000; Schneider and Stephens, 1990).
Acknowledgments
This work was sponsored by the NIH/NIAID Regional Center of
Excellence for Biodefense and Emerging Infectious Diseases Research
(RCE) Program. The authors wish to acknowledge membership within
and support from the Region V ‘Great Lakes’ RCE (NIH award 1-U54-AI-057153). We thank the UW Madison Biotechnology mass spectro-
metry facility and the Human Proteomics Mass Spectrometry Facility
supported by the “TheWisconsin Partnership Fund for a Healthy Future”
for technical assistance. We also thank Janet Smith and Richard Kuhn
for helpful discussions, and Deane Mosher for comments on drafts of
this manuscript.
Appendix A. Supplementary data
Supplementary data associatedwith this article can be found, in the
online version, at doi:10.1016/j.virol.2008.07.013.
References
Assenberg, R., Ren, J., Verma, A., Walter, T.S., Alderton, D., Hurrelbrink, R.J., Fuller, S.D.,
Bressanelli, S., Owens, R.J., Stuart, D.I., Grimes, J.M., 2007. Crystal structure of the
Murray Valley encephalitis virus NS5 methyltransferase domain in complex with
cap analogues. J. Gen. Virol. 88 (Pt 8), 2228–2236.
Black, T.M., Andrews, C.L., Kilili, G., Ivan, M., Tsichlis, P.N., Vouros, P., 2007.
Characterization of phosphorylation sites on Tpl2 using IMAC enrichment and a
linear ion trap mass spectrometer. J. Proteome Res. 6 (6), 2269–2276.
Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S., Brunak, S., 2004. Prediction of
post-translational glycosylation and phosphorylation of proteins from the amino
acid sequence. Proteomics 4 (6), 1633–1649.
Coleman, T.M., Wang, G., Huang, F., 2004. Superior 5′ homogeneity of RNA from ATP-
initiated transcription under the T7 phi 2.5 promoter. Nucleic Acids Res. 32 (1), e14.
Crooks, G.E., Hon, G., Chandonia, J.M., Brenner, S.E., 2004. WebLogo: a sequence logo
generator. Genome Res. 14 (6), 1188–1190.
Dong, H., Ray, D., Ren, S., Zhang, B., Puig-Basagoiti, F., Takagi, Y., Ho, C.K., Li, H., Shi, P.Y.,
2007. Distinct RNA elements confer speciﬁcity to ﬂavivirus RNA cap methylation
events. J. Virol. 81 (9), 4412–4421.
Dong, H., Ren, S., Zhang, B., Zhou, Y., Puig-Basagoiti, F., Li, H., Shi, P.Y., 2008. West Nile
Virus methyltransferase catalyzes two methylations of the viral RNA cap through a
substrate-repositioning mechanism. J. Virol. 82 (9), 4295–4307.
Egloff, M.P., Benarroch, D., Selisko, B., Romette, J.L., Canard, B., 2002. An RNA cap
(nucleoside-2′-O-)-methyltransferase in the ﬂavivirus RNA polymerase NS5: crystal
structure and functional characterization. Embo J. 21 (11), 2757–2768.
Egloff, M.P., Decroly, E., Malet, H., Selisko, B., Benarroch, D., Ferron, F., Canard, B., 2007.
Structural and functional analysis of methylation and 5′-RNA sequence require-
ments of short capped RNAs by the methyltransferase domain of dengue virus NS5.
J. Mol. Biol. 372 (3), 723–736.
Fabrega, C., Hausmann, S., Shen, V., Shuman, S., Lima, C.D., 2004. Structure and
mechanism of mRNA cap (guanine-N7) methyltransferase. Mol. Cell. 13 (1), 77–89.
Forwood, J.K., Brooks, A., Briggs, L.J., Xiao, C.Y., Jans, D.A., Vasudevan, S.G., 1999. The 37-
amino-acid interdomain of dengue virus NS5 protein contains a functional NLS and
inhibitory CK2 site. Biochem. Biophys. Res. Commun. 257 (3), 731–737.
Furuichi, Y., Shatkin, A.J., 2000. Viral and cellular mRNA capping: past and prospects.
Adv. Virus Res. 55, 135–184.
Hiscock, D., Upton, C., 2000. Viral Genome DataBase: storing and analyzing genes and
proteins from complete viral genomes. Bioinformatics 16 (5), 484–485.
Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., Pease, L.R., 1989. Site-directed
mutagenesis by overlap extension using the polymerase chain reaction. Gene 77
(1), 51–59.
Holden, K.L., Stein, D.A., Pierson, T.C., Ahmed, A.A., Clyde, K., Iversen, P.L., Harris, E., 2006.
Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer
targeted to the top of the terminal 3′ stem-loop structure. Virology 344 (2), 439–452.
Jakubiec, A., Jupin, I., 2007. Regulation of positive-strand RNA virus replication: the
emerging role of phosphorylation. Virus Res. 129 (2), 73–79.
Jones, C.T., Patkar, C.G., Kuhn, R.J., 2005. Construction and applications of yellow fever
virus replicons. Virology 331 (2), 247–259.
Kapoor, M., Zhang, L., Ramachandra, M., Kusukawa, J., Ebner, K.E., Padmanabhan, R.,
1995. Association between NS3 and NS5 proteins of dengue virus type 2 in the
putative RNA replicase is linked to differential phosphorylation of NS5. J. Biol.
Chem. 270 (32), 19100–19106.
Khromykh, A.A., Kenney, M.T., Westaway, E.G., 1998. trans-Complementation of
ﬂavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing
BHK cells. J. Virol. 72 (9), 7270–7279.
Khromykh, A.A., Sedlak, P.L., Guyatt, K.J., Hall, R.A., Westaway, E.G., 1999. Efﬁcient trans-
complementation of the ﬂavivirus Kunjin NS5 protein but not of the NS1 protein
requires its coexpression with other components of the viral replicase. J. Virol. 73
(12), 10272–10280.
Kim, S.J., Kim, J.H., Kim, Y.G., Lim, H.S., Oh, J.W., 2004. Protein kinase C-related kinase 2
regulates hepatitis C virus RNA polymerase function by phosphorylation. J. Biol.
Chem. 279 (48), 50031–50041.
Mastrangelo, E., Bollati, M., Milani, M., Selisko, B., Peyrane, F., Canard, B., Grard, G.,
de Lamballerie, X., Bolognesi, M., 2007. Structural bases for substrate recognition
and activity in Meaban virus nucleoside-2′-O-methyltransferase. Protein Sci. 16 (6),
1133–1145.
Modrof, J., Muhlberger, E., Klenk, H.D., Becker, S., 2002. Phosphorylation of VP30 impairs
ebola virus transcription. J. Biol. Chem. 277 (36), 33099–33104.
Mohr, I., 2006. Phosphorylation and dephosphorylation events that regulate viralmRNA
translation. Virus Res. 119 (1), 89–99.
284 D. Bhattacharya et al. / Virology 380 (2008) 276–284Morozova, O.V., Tsekhanovskaya, N.A., Maksimova, T.G., Bachvalova, V.N., Matveeva,
V.A., Kit, Y., 1997. Phosphorylation of tick-borne encephalitis virus NS5 protein.
Virus Res. 49 (1), 9–15.
Neddermann, P., Quintavalle, M., Di Pietro, C., Clementi, A., Cerretani, M., Altamura, S.,
Bartholomew, L., De Francesco, R., 2004. Reduction of hepatitis C virus NS5A
hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA
replication in cell culture. J. Virol. 78 (23), 13306–13314.
Pryor, M.J., Rawlinson, S.M., Butcher, R.E., Barton, C.L., Waterhouse, T.A., Vasudevan,
S.G., Bardin, P.G., Wright, P.J., Jans, D.A., Davidson, A.D., 2007. Nuclear localization
of dengue virus nonstructural protein 5 through its importin alpha/beta-
recognized nuclear localization sequences is integral to viral infection. Trafﬁc 8
(7), 795–807.
Quintavalle, M., Sambucini, S., Summa, V., Orsatti, L., Talamo, F., De Francesco, R.,
Neddermann, P., 2007. Hepatitis C virus NS5A is a direct substrate of casein
kinase I-alpha, a cellular kinase identiﬁed by inhibitor afﬁnity chromatography
using speciﬁc NS5A hyperphosphorylation inhibitors. J. Biol. Chem. 282 (8),
5536–5544.Ray, D., Shah, A., Tilgner, M., Guo, Y., Zhao, Y., Dong, H., Deas, T.S., Zhou, Y., Li, H., Shi,
P.Y., 2006. West Nile virus 5′-cap structure is formed by sequential guanine N-7
and ribose 2¢-O methylations by nonstructural protein 5. J. Virol. 80 (17),
8362–8370.
Reed, K.E., Gorbalenya, A.E., Rice, C.M., 1998. The NS5A/NS5 proteins of viruses from
three genera of the family ﬂaviviridae are phosphorylated by associated serine/
threonine kinases. J. Virol. 72 (7), 6199–6206.
Schneider, T.D., Stephens, R.M., 1990. Sequence logos: a new way to display consensus
sequences. Nucleic Acids. Res. 18 (20), 6097–6100.
Schubert, H.L., Blumenthal, R.M., Cheng, X., 2003. Many paths to methyltransfer: a
chronicle of convergence. Trends Biochem. Sci. 28 (6), 329–335.
Unger, B., Traktman, P., 2004. Vaccinia virus morphogenesis: a13 phosphoprotein is
required for assembly of mature virions. J. Virol. 78 (16), 8885–8901.
World Health Organization, 2002. Dengue Factsheet. WHO.
Zhou, Y., Ray, D., Zhao, Y., Dong, H., Ren, S., Li, Z., Guo, Y., Bernard, K.A., Shi, P.Y., Li, H.,
2007. Structure and function of ﬂavivirus NS5 methyltransferase. J. Virol. 81 (8),
3891–3903.
